These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35521021)

  • 1. Transdermal Patch Administration and Magnetic Resonance Imaging (MRI)-2020.
    Afanasjeva J; Gabay M; Poznanski T; Kerns S
    Hosp Pharm; 2022 Feb; 57(1):117-120. PubMed ID: 35521021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Term Safety and Efficacy of Blonanserin Transdermal Patches in Japanese Patients with Schizophrenia: A 52-Week Open-Label, Multicenter Study.
    Iwata N; Ishigooka J; Naoi I; Matsumoto M; Kanamori Y; Nakamura H; Higuchi T
    CNS Drugs; 2020 Jan; 34(1):103-116. PubMed ID: 31883082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety Problems With a Transdermal Patch for Migraine: Lessons From the Development, Approval, and Marketing Process.
    Loder EW; Rayhill M; Burch RC
    Headache; 2018 Nov; 58(10):1639-1657. PubMed ID: 30367818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Model analysis of tulobuterol patch formulations to explain the influence of drug release rate and transdermal transfer rate on the plasma concentration profile].
    Watanabe T; Satoh H; Hori S; Miki A; Ohtani H; Sawada Y
    Yakugaku Zasshi; 2011; 131(10):1483-92. PubMed ID: 21963976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimizing transdermal drug therapy.
    Ball AM; Smith KM
    Am J Health Syst Pharm; 2008 Jul; 65(14):1337-46. PubMed ID: 18593680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practical considerations for optimal transdermal drug delivery.
    Durand C; Alhammad A; Willett KC
    Am J Health Syst Pharm; 2012 Jan; 69(2):116-24. PubMed ID: 22215357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transdermal buprenorphine patches applied in a 4-day regimen versus a 3-day regimen: a single-site, Phase III, randomized, open-label, crossover comparison.
    Likar R; Lorenz V; Korak-Leiter M; Kager I; Sittl R
    Clin Ther; 2007 Aug; 29(8):1591-606. PubMed ID: 17919542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential risks of pharmacy compounding.
    Gudeman J; Jozwiakowski M; Chollet J; Randell M
    Drugs R D; 2013 Mar; 13(1):1-8. PubMed ID: 23526368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy, safety and pharmacokinetic study of a novel fentanyl-containing matrix transdermal patch system in Japanese patients with cancer pain.
    Miyazaki T; Hanaoka K; Namiki A; Ogawa S; Kitajima T; Hosokawa T; Ishida T; Nogami S; Mashimo S
    Clin Drug Investig; 2008; 28(5):313-25. PubMed ID: 18407717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solid-State Stability Issues of Drugs in Transdermal Patch Formulations.
    Sharma PK; Panda A; Pradhan A; Zhang J; Thakkar R; Whang CH; Repka MA; Murthy SN
    AAPS PharmSciTech; 2018 Jan; 19(1):27-35. PubMed ID: 28895101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transdermal patches for the treatment of neurologic conditions in elderly patients: a review.
    Farlow MR; Somogyi M
    Prim Care Companion CNS Disord; 2011; 13(6):. PubMed ID: 22454804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alghedon Fentanyl Transdermal System.
    Romualdi P; Santi P; Candeletti S
    Minerva Med; 2017 Apr; 108(2):169-175. PubMed ID: 27886163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of transdermal patches and solid microneedles for improved transdermal delivery of primaquine.
    Ananda PWR; Elim D; Zaman HS; Muslimin W; Tunggeng MGR; Permana AD
    Int J Pharm; 2021 Nov; 609():121204. PubMed ID: 34662646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allowable room temperature excursions for refrigerated medications: A 20-year review.
    Orth LE; Ellingson AS; Azimi SF; Martinez JT; Alhadad AA; Tran BC; Allen CW; Nguyen CT; Duong T; Burkdoll JS; Yoo J; Blackmer AB; Jeffres MN
    Am J Health Syst Pharm; 2022 Jul; 79(15):1296-1300. PubMed ID: 35451022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zelrix: a novel transdermal formulation of sumatriptan.
    Pierce M; Marbury T; O'Neill C; Siegel S; Du W; Sebree T
    Headache; 2009 Jun; 49(6):817-25. PubMed ID: 19438727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drugs to Be Used With a Filter for Preparation and/or Administration-2019.
    Ipema HJ; Zacher JM; Galka E; Nazari J; Varabyeva A; Yu M; Hartke P
    Hosp Pharm; 2021 Apr; 56(2):81-87. PubMed ID: 33790482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Approvals and Timing of New Formulations of Novel Drugs Approved by the US Food and Drug Administration Between 1995 and 2010 and Followed Through 2021.
    Gupta R; Morten CJ; Zhu AY; Ramachandran R; Shah ND; Ross JS
    JAMA Health Forum; 2022 May; 3(5):e221096. PubMed ID: 35977259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic review of medication administration errors with transdermal patches.
    Lampert A; Seiberth J; Haefeli WE; Seidling HM
    Expert Opin Drug Saf; 2014 Aug; 13(8):1101-14. PubMed ID: 24921682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patches: Established and Emerging Transdermal Treatments in Psychiatry.
    Citrome L; Zeni CM; Correll CU
    J Clin Psychiatry; 2019 Jul; 80(4):. PubMed ID: 31318185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.